Kidney organogenesis is initiated with the formation of the pronephric kidney and requires Pax-2 gene function. We report here the cloning and characterization of Pax-2 cDNAs from the frog Xenopus laevis, a model system suitable for the study of early kidney organogenesis. We show that expression of Xenopus Pax-2 (XPax-2) genes was confined to the nervous system, sensory organs, the visceral arches, and the developing excretory system. DNA sequencing of XPax-2 cDNAs isolated from head and pronephric kidney libraries revealed seven novel alternatively spliced Pax-2 isoforms. They all retain DNA-binding domains, but can differ significantly in their C termini with some isoforms containing a novel Pax-2 exon. We investigated the spectrum of XPax-2 splice events in pronephric kidneys, animal cap cultures and in whole embryos. Splicing of XPax-2 transcripts was found to be extensive and temporally regulated during Xenopus embryogenesis. Since all investigated tissues expressed essentially the full spectrum of XPax-2 splice variants, we conclude that splicing of XPax-2 transcripts does not occur in a tissue-specific manner.
Introduction
The development of the vertebrate excretory system is characterized by the successive formation of three distinct kidneys, the pronephros, the mesonephros and the metanephros (Saxén, 1987) . All three kidneys are derived from the intermediate mesoderm and appear in a precise temporal and spatial sequence during embryogenesis. The pronephros is established as the earliest and most anterior kidney and represents the simplest form of an excretory organ in vertebrates. Its structural organization consisting of two components, a tubular system and an excretory duct, has already been recognized in the early nineteenth century through anatomical studies of amphibian embryos (Müller, 1829) . As with all kidneys, the basic excretory unit of the pronephric kidney is the nephron. Each nephron is initially composed of a glomerulus and a segmented tubular system. As development proceeds, the pronephric glomeruli fuse to a single vascularized glomus. Pronephric tubules are lined by diverse epithelial cell types and are connected at their proximal ends to the coelomic cavity via ciliated funnels (nephrostomes). Individual nephrons are linked together through connecting tubules, which fuse to a single broad collecting tubule that communicates with the pronephric (or Wolffian) duct (Fraser, 1950; Fox, 1963) . The organization of pronephric nephrons is therefore very much like that of the more advanced mesonephric and metanephric kidneys. A major difference lies in the number of nephrons that comprises the different kidney types. While the metanephric kidney of humans can contain up to 1 million nephrons, the pronephric kidney of amphibians is typically composed of 2-3 nephrons. This simple structural organization makes the pronephric kidney an attractive system to study kidney organogenesis (Fox, 1963; Vize et al., 1995) .
Maturation of the pronephric kidney into a functional excretory organ is restricted to larval stages of fish and amphibians. It mediates the excretion of metabolic end products from the blood, the reabsorption of ions, and the control of water balance, and is therefore essential for the survival of the embryo (Fox, 1963) . In higher vertebrates, pronephric tubule differentiation remains rudimentary, but pronephric duct formation proceeds normally (Burns, 1955; Saxén, 1987) . The pronephric duct and its derivatives participate in the induction of both the mesonephric and metanephric kidneys of vertebrate embryos (Burns, 1955; Saxén, 1987; Herzlinger, 1995; ) . In amphibian embryos, the isolated pronephric duct has been shown to act in vitro as a strong inducer of mesonephric tubules if combined with explants of mesonephric mesenchyme (Etheridge, 1968) . Similarly, induction of the metanephric kidney is dependent on the ureteric bud, an epithelial diverticulum that forms from the caudal aspects of the pronephric duct. Ablation of the ureteric bud impairs metanephric kidney formation (Gruenwald, 1952; Grobstein, 1955; Saxén, 1987) . While the role of the pronephric duct as an inducer of the mesonephric and metanephric kidneys is clearly established, it is currently not known whether a similar function is also necessary for proper pronephric kidney development. Since pronephric duct and tubules arise from separate but adjacent populations of primordial cells of the intermediate mesoderm (O'Connor, 1938; Vize et al., 1995) , it is however conceivable that inductive interactions exerted by the pronephric duct could also promote pronephric tubule differentiation.
The molecular mechanisms underlying kidney organogenesis are in general still poorly understood. An ever growing number of molecules with supposed regulatory and signaling functions have been found to be expressed at various stages of kidney development (Davies and Brändli, 1996) . The use of in vitro organ culture systems and genetic evidence provided by transgenic animal models has helped to define essential components of an emerging network of signaling pathways that regulate metanephric kidney development (Herzlinger, 1995; Ekblom, 1996; Lechner and Dressler, 1997) . These components include growth factors of the Wingless/int (e.g. Wnt-4), transforming growth factor-b (e.g. GDNF), and bone morphogenetic protein (e.g. BMP-7) families; adhesion molecules (e.g. integrin a8), receptor tyrosine kinases (e.g. c-Ret), and transcriptions factors (e.g. BF-2, Emx-2 and WT-1). None of these gene products however appear to be absolutely necessary for normal pronephric and mesonephric kidney development. Thus, the nature of the molecules regulating early stages of kidney organogenesis remains still unresolved.
Transcription factors of the Pax class comprise a small, but important family of developmental control genes Stuart et al., 1994; Mansouri et al., 1996) . Pax genes are defined by a 128-amino acid DNA binding domain, called the paired box domain, which is conserved in animal species ranging from nematodes to humans, and was originally identified in the Drosophila segmentation gene paired (Bopp et al., 1986) . Based on sequence homology and the presence of class-specific amino acids in certain positions, the known paired domains can be divided into six different classes (Walther et al., 1991; Noll, 1993; Nornes et al., 1996) . Each member of the family shows spatially and temporally restricted expression patterns during embryonic development, with the majority of Pax genes being expressed in the central nervous system and/or the paraxial mesoderm and its derivatives Mansouri et al., 1996) . Pax-2 is of particular interest with respect to kidney organogenesis. Pax-2 together with Pax-5 and Pax-8 comprise the class III Pax gene family (Walther et al., 1991) . They contain an octapeptide motif and only a partial homeodomain. Pax-2 gene expression is associated with the earliest stages of kidney organogenesis Krauss et al., 1991; Mikkola et al., 1992; Püschel et al., 1992) . Transcripts of Pax-2 are initially present in the pro-and mesonephric tubules, as well as in the pronephric duct and its derivatives. Later, Pax-2 expression is found in the condensing metanephric mesenchyme, its early epithelial derivatives, and in the collecting duct epithelium. Pax-2 transcripts are however never associated with the undifferentiated mesenchyme.
A number of mutations in the Pax-2 gene reported recently establishes a central role for Pax-2 in kidney organogenesis. In two human families, heterozygosity for Pax-2 mutations cause renal-coloboma syndrome (Sanyanusin et al., 1995a,b) . Patients display eye defects and kidney hypoplasia. The mutations appear to be loss-of-function mutations implying a dosage-sensitivity, haplo-insufficiency, for Pax-2. In mice, three strains with mutation in the Pax-2 gene have been reported. The Krd strain carries a large chromosomal deletion affecting several genes including the Pax-2 locus (Keller et al., 1994) . Torres et al. (1995) have generated Pax-2-deficient mice by targeted mutagenesis. A spontaneous mouse mutant carrying the Pax-2 1Neu mutation was found to be identical to a previously described human Pax-2 mutation (Favor et al., 1996) . All three mice mutants show that a partial loss of Pax-2 gene dosage results in similar renal defects as in humans (Keller et al., 1994; Torres et al., 1995; Favor et al., 1996) . Animals homozygous for mutations in the Pax-2 gene are more severely affected and completely lack mesonephric and metanephric kidneys, ureters, and genital tracts (Torres et al., 1995; Favor et al., 1996) . The pronephric duct develops only rudimentary, and then degenerates at the point when it should begin to interact with the nephrogenic mesenchyme. Outside the excretory system, defects are also seen with neural tube closure and the development of the optic nerve, the inner ear, and structures at the midbrain-hindbrain boundary (Sanyanusin et al., 1995a,b; Favor et al., 1996; Torres et al., 1996) . Recently, defects in nervous system, sensory organs and kidneys were reported for zebrafish strains harboring mutations in the noisthmus (noi) gene which encodes a possible homologue of mammalian Pax-2 (Brand et al., 1996; Macdonald et al., 1997) .
The nature of the kidney defects observed in homozygous mutant animals define Pax-2 as an essential component of the intermediate mesoderm necessary for normal pronephric kidney development. Being a transcription factor, Pax-2 may be directly controlling regulatory hierarchies of genes involved in this process. To address the mechanism of Pax-2 function in an experimental system suitable for studies on early kidney organogenesis, we have isolated cDNAs encoding seven novel isoforms of Pax-2 from Xenopus head and pronephric kidney libraries. We document here the spatial pattern of Xenopus Pax-2 gene expression during embryogenesis with an emphasis on pronephric kidney development. Further, we assess the complexity of XPax-2 isoform expression in embryos, animal cap cultures and developing pronephric kidneys. We found that alternative splicing of XPax-2 transcripts was temporally regulated. The profiles of XPax-2 isoform expression were however similar for all tissues examined. Our results indicate that the mechanism controlling alternative splicing of XPax-2 transcripts during early Xenopus embryogenesis is not regulated in a tissue-specific manner.
Results

Cloning and sequence analysis of cDNAs encoding Pax-2 homologues from Xenopus laevis
The reverse transcription-polymerase chain reaction (RT-PCR) was chosen as a strategy to isolate a Xenopus Pax-2 (XPax-2) specific nucleic acid probe. Invariant sequence motifs within the highly conserved paired domain of class III Pax genes were selected to derive degenerate oligonucleotide primers (Fig. 1A) . Sequence analysis of 88 bacterial clones containing subcloned RT-PCR generated cDNA fragments allowed us to distinguish five different classes. The majority of the analyzed sequences (Ͼ95%) displayed highest homology to human Pax-2 and could be divided into two closely related subclasses. The two subclasses represent transcripts of two pseudoallelic genes for Pax-2 in Xenopus laevis, which we have termed XPax-2a and XPax-2b. The remaining sequences displayed highest homology to either Pax-5, Pax-6, or Pax-9. Next, we used XPax-2-specific cDNA fragments to screen a Xenopus stage 28-30 head cDNA library (Hemmati-Brivanlou et al., 1991) in order to obtain cDNA sequences harboring a complete open reading frame. Three full-length cDNAs were isolated: XPax2a(1), XPax-2a(3), and XPax-2b(2). DNA sequencing allowed us to assign two cDNAs as transcripts of the XPax-2a gene, while the third was derived from XPax-2b. An alignment of the predicted protein products is shown in Fig. 1A . The three XPax-2 proteins are essentially collinear with each other over the first 300 amino acids. Within this region, their amino acid sequences are almost identical (5 amino acids differences between the XPax-2a and XPax-2b proteins; 98.3% identity). This degree of identity is characteristic for gene products of pseudoallelic Xenopus genes (Graf and Kobel, 1991) . Vertebrate class III Pax genes are defined by the presence of three conserved sequence motifs: the paired domain, the octapeptide, and a partial homeodomain (Walther et al., 1991) . All three XPax-2 proteins were found to display the same characteristic sequence motifs (Fig. 1A) . A comparison of these motifs with the three human class III Pax proteins consistently indicated highest homology to human Pax-2 (Fig. 2) . For XPax-2a(1), the amino acid identity was found to be 100% within the paired domain and the octapeptide motif (not shown), and 96% for the partial homeodomain. The identity in the Cterminal domain to human Pax-2 was with 87% somewhat lower, but still significantly higher than to human Pax-5 and Pax-8. Comparisons of Pax-2 proteins from zebrafish (previously referred to as Pax-B or pax [zf-b] ) and mouse to human Pax-2 revealed a similar degree of identity (Fig.  2) . We conclude that XPax-2a and XPax-2b represent unambiguously Xenopus homologues of the human Pax-2 gene.
Comparison of the C-terminal region of the XPax-2 cDNA sequences revealed that the extensive homologies in the open-reading frames are interrupted by intervening nucleotide sequences downstream of the partial homeodomain (Fig. 1A) . Relative to XPax-2a(1), XPax-2b(3) contains a 210 bp insertion, while XPax-2a(3) contains one of 99 bp. The extreme C-termini are again completely collinear. The intervening sequences do not alter the reading frame of the coding sequence. It is likely that these insertions represent alternative splice events during the maturation of XPax-2 transcripts. In humans, three Pax-2 variants generated by alternative splicing have been described (Eccles et al., 1992; Ward et al., 1994; Sanyanusin et al., 1996) . Insertion of exon 6 between the octapeptide and the partial homeodomain generates a variant of human Pax-2, called here human Pax-2(E6) (Sanyanusin et al., 1996) . Pax-2 isoforms homologous to human Pax-2(E6) have been described in zebrafish and mouse Krauss et al., 1991) . Human Pax-2(E10) is generated by inclusion of exon 10. In this case, an alteration of the reading frame occurs and thereby produces a protein with an alternative C-terminus (Ward et al., 1994) . We performed multiple sequence alignments to compare the variants of Xenopus Pax-2 with the known human Pax-2 isoforms (Fig. 1B) . All three Xenopus Pax-2 isoforms lacked intervening sequences at a site equivalent to the exon 6 insertion in human Pax-2(E6). XPax-2a(1) was found to be homologous to the initially reported human Pax-2 protein (Eccles et al., 1992 ) which lacks exon 6 and exon 10 (data not shown). XPax-2a(3) is equivalent to human Pax-2(E10), with the exception that in Xenopus this alternative splicing event retains the original reading frame. XPax-2b(2) with its intervening sequence of 210 bp did not match any of the known vertebrate Pax-2 splice variants. The sequence alignment predicts that the alternative splice event occurs exactly at the junction of the human Pax-2 exon 8 and 9 (Fig. 1B) . Transcripts of the related human Pax-8 gene are also subject to alternative splicing (Poleev et al., 1992; Poleev et al., 1995; Kozmik et al., 1993) . Interestingly, a comparison of human Pax-8 and Xenopus Pax-2 isoforms revealed that XPax-2b(2) matched human Pax-8a including the novel intervening sequence (Fig. 1B) . The alternatively spliced sequence of human Pax-8a is encoded by a separate exon (Kozmik et al., 1993; Poleev et al., 1995) and displays significant sequence homology to the Xenopus sequence (35.7% identity; 25 out of 70 amino acids). Taken together, the provided evidence suggests that the intervening sequence found in the C terminus of XPax-2b(2) might be encoded by a novel Pax-2 exon. Fig. 1 . Amino acid sequences of Xenopus Pax-2 cDNAs and comparison of exon composition with human Pax-2 and Pax-8 splice variants. (A) Alignment of the deduced amino acid sequences of full-length Xenopus Pax-2 isoforms. The amino acid sequences are shown in single letter code. Gaps introduced to maximize similarity in the sequences are shown as dots. Amino acids differing between pseudoallelic Xenopus Pax-2a and Pax-2b isoforms are boxed. The amino acid sequence motifs recognized by the degenerate PCR primers XP-1 and XP-2, respectively, are indicated by arrows. The paired domain is shown with a black line, the octapeptide motif with a double line, and the partial homeodomain with a broken black line. Asterisks denote the approximate locations of introns that were identified by sequencing of the human Pax-2 gene (Sanyanusin et al., 1996) . (B) Comparison of Xenopus Pax-2 splice variants with human Pax-2 and Pax-8 isoforms. Only sequences down-stream of the octapeptide motif are shown. hPax-2(E6) represents a splice variant of human Pax-2 containing exon 6 (Sanyanusin et al., 1996) . hPax-2(E10) includes exon 10, which results in an alteration of the reading frame and thereby produces an alternative C-terminus (Ward et al., 1994) . The sequence of human Pax-8a was taken from (Poleev et al., 1992) . The exon organization of the coding sequence of human Pax-2 (Sanyanusin et al., 1996) is outlined beneath the sequence alignment. The exons of human Pax-2 are numbered from hE5 to hE12 and their boundaries are indicated by arrows. Note the gap between hE8 and hE9 generated by including XPax-2b(2) in the alignment. Human Pax-8a contains an alternatively spliced exon at the equivalent position.
Spatial expression of XPax-2 transcripts during early neural development, in sensory organs and visceral arches
We performed whole mount in situ hybridization using digoxigenin-labeled RNA probes (Harland, 1991) to determine the spatial expression of XPax-2 in the developing Xenopus embryo. Several different probes were constructed and tested in hybridizations with consistent results. These include probes covering the entire coding sequence, as well as such that exclude the conserved paired domain of each XPax-2 isoform (data not shown; see Section 4 for details). For maximal sensitivity, only results from hybridizations with probes directed against the entire coding sequence of XPax-2a(1) are shown (Fig. 3) . Expression of localized XPax-2 transcripts was first detected at the end of gastrulation and was thereafter seen throughout embryogenesis (Fig.  3 ). Transcripts were essentially confined to the nervous system (midbrain, hindbrain, spinal cord), sensory organs (optic vesicle and stalk, otic vesicle), the visceral arches, and the excretory system (pronephros, pronephric duct, rectal diverticulum, proctodaeum).
In the developing Xenopus nervous system, the earliest site of localized XPax-2 transcription was detected at stage 13 (early neurula) in the anterior 1/3 of the neural plate (Fig.  3A,B) . XPax-2 expression was associated with two distinct wedge-shaped patches of cells flanking the midline, separated by a small region devoid of expression. In the course of neural tube closure, the two patches of XPax-2 expression converge towards the dorsal midline (Fig. 3C,D) . These cells will ultimately form the posterior portion of the midbrain at the midbrain-hindbrain boundary (Fig. 3K) . Expression of XPax-2 in the hindbrain became discernible at stage 24 and was initially confined to a region posterior to the otic vesicle (Fig. 3F) . Later, expression started to spread also anteriorly. Finally, XPax-2-expressing cells were found throughout the hindbrain (Fig. 3I ). Transversal sections at the level of the hindbrain-spinal cord junction revealed XPax-2-expressing cells at a ventrolateral location in the neural tube (Fig. 3M) . A first indication of Pax-2 expression associated with neurons of the developing spinal cord became apparent in embryos of stage 19 (Fig. 3D ). Expression was initially confined to the anterior 1/3 of the spinal cord (Fig. 3E ). As spinal cord differentiation proceeds in the posterior direction, additional clusters of cells expressing XPax-2 were detected. By stage 32, clusters of XPax-2 expressing cells were found extending along all but the most posterior part of the spinal cord (Fig. 3H ). Dorsal inspection of stained embryos revealed that the Pax-2 expressing cells appeared as two longitudinal columns (Fig. 3D) . By sectioning transversally through the spinal cord, we were able to show that cells expressing XPax-2 were confined to an intermediate position along the dorsalventral axis of the spinal cord (data not shown). Based on this location, these cells most likely represent interneurons (Hartenstein, 1993; Roberts and Clarke, 1982) .
XPax-2 expression was also found to be associated with the development of two sensory organs, the eye and the ear. For the eye, XPax-2 transcripts were initially detected at stage 19 (late neurula) as a faint signal in the region of the future optic stalk and vesicle (Fig. 3C) . By stage 21, expression was very prominent, and remained high during later stages as the optic stalk constricts and the optic vesicle invaginates. In transverse sections, XPax-2 transcripts were associated with the ventral region of the optic cup (Fig. 3L) . In tadpole stage embryos, XPax-2 expression was gradually down-regulated, first in the optic cup, and then in the optic stalk (Fig. 3K) . The onset of XPax-2 transcription in the developing ear correlated with otic placode induction (Fig. 3E) . Invagination starts at stage 23, and separation from the epidermis is achieved by stage 28 (Nieuwkoop and Faber, 1956 ). XPax-2 expression remained associated with the otic vesicle throughout this period. By stage 39, XPax-2 expression was gradually down-regulated in the epithelium of the otic vesicle, but still remained in a patch of dorso-medially located cells (Fig. 3J, K) . (Bopp et al., 1986; Walther et al., 1991) . The partial homeodomain is defined as 30-amino acid motif according to (Krauss et al., 1991) . The C-terminal domain (137-140 amino acid residues in length) covers the entire region downstream of the partial homeodomain motif using human Pax-2 as a reference. To improve the alignment, intervening sequences generated by alternative splicing were removed from human Pax-8. The sequences were taken from the following sources: mouse Pax-2 with corrections according to (Adams et al., 1992) ; zebrafish Pax-2, originally described as pax [zf-b] (Krauss et al., 1991) ; human Pax-2 (Eccles et al., 1992) ; human Pax-5 (Adams et al., 1992) ; human Pax-8 (Poleev et al., 1992) .
Pax-2 expression in the context of visceral arch development has so far not been described. In Xenopus, we noticed three prominent stripes of XPax-2 expression which were associated with the visceral arches from stages 24 to 32 ( Fig.  3F-H) . Visceral arches, referred to as branchial or pharyngeal arches in higher vertebrates, are important for the development of the entire neck region in all vertebrate embryos (Carlson, 1996) . The arches originate as bars of mesenchyme sculpted from the sides of the neck by pairs of visceral (or pharyngeal) pouches, which bulge out from the foregut endoderm. Where a visceral pouch approaches the overlying ectodermally-derived epidermis, it displaces the surrounding mesenchymal tissue and induces the formation of a furrow. In Xenopus, three visceral furrows have been described (Nieuwkoop and Faber, 1956) . Each visceral arch is composed of epithelial layers of both ectodermal and endodermal origin, and contains premuscle mesenchyme of mesoderm origin, and a cranial nerve and a skeletal primordium of neural crest origin. We carried out horizontal sections to determine which of these tissues is associated with XPax-2 expression (Fig. 3N ). XPax-2 transcripts were limited to the epidermal layer and highest concentrations were found in the three visceral furrows. Once embryos reached stage 36, the expression ceased (Fig. 3I) .
Expression of XPax-2 in the developing pronephric kidney
The first morphological indication of the pronephric anlage is seen at stage 21 as a slight thickening of the somatic layer of the intermediate mesoderm below somites 3 and 4 (Nieuwkoop and Faber, 1956 ). This corresponds exactly to the first time at which XPax-2 staining could be detected in the developing pronephric kidney. The embryos showed Pax-2 expression in a small extended stripe of tissue below the somites (Fig. 3E) . By stage 24, the stripe of cells had extended in posterior direction with the future pronephros and pronephric duct becoming now discernible (Fig.  3F ). The subsequent development of the pronephric kidney is characterized by the differentiation of the pronephros (into nephrostomes, tubular canaliculi and the collecting tube), the elongation of the pronephric duct, and the outgrowth of the rectal diverticulum. XPax-2 expression remained associated with the epithelial components of the pronephric kidney during each of these morphogenetic processes ( Fig. 3G-K ). Transverse sections of stained embryos confirmed expression in the pronephros (Fig. 3M ). Formation of the three nephrostomes begins at stage 28 and is completed by stage 34. This process was accompanied by a significant increase in XPax-2 expression as illustrated by three strongly stained spots in the pronephros (Fig. 3H,K) . Expression of XPax-2 was also seen throughout the tubular system which was undergoing extensive coiling (Fig. 3K ). The excretory canal is formed by fusion of two elongating epithelial components, the pronephric duct and the rectal diverticulum. Posterior elongation of the pronephric duct starts at stage 26, and continues until stage 36/37, when fusion with the rectal diverticulum occurs (Fig. 3H-J) . The rectal diverticulum is formed from a bulge of the dorsal wall of the proctodaeum at stage 32 and grows in the anterior direction to make contact with the posterior growing pronephric duct. XPax-2 expression was detected starting from stage 28 in the region of the proctodaeum and became later also associated with the outgrowing rectal diverticulum (Fig. 3G,H) . Expression of XPax-2 in the proctodaeum was subsequently down-regulated, first only ventrally and, later, also in dorsal aspects. By stage 39, XPax-2 expression remained in the epithelium of the excretory canal up to the point, where it fuses with the cloaca (compare Fig.  4H -J).
Isolation of cDNAs encoding novel XPax-2 isoforms from the developing pronephric kidney
The isolation of cDNAs encoding novel Pax-2 isoforms from a Xenopus head cDNA library prompted us to investigate alternative splicing of Pax-2 transcripts in the developing pronephric kidney. For this purpose, a cDNA library of XPax-2 cDNAs was prepared from RNA of stage 24 explants enriched for pronephroi (for dissection strategy, Fig. 3 . Spatial expression of XPax-2 transcripts during early Xenopus embryogenesis. Whole mount in situ hybridizations were performed on albino embryos using digoxigenin-labeled antisense RNA probes. Hybridization events were visualized as alkaline phosphatase chromogenic reaction products. Embryos stained in whole mount were used for sectioning and were cut at 70 mm (L, M) and 100 mM (N). (A, B) Lateral and dorsal views of a stage 13 embryo. XPax-2 expression is seen in two wedge-shaped patches of cells in the anterior 1/3 of the neural plate. Expression is absent at the midline (arrowhead). (C) Lateral view of a stage 19 embryo. XPax-2 expression can be detected in the regions of the future midbrain-hindbrain boundary and the optic stalk (arrowhead). (D) Dorsal view of a stage 19 embryo. Two rectangular-shaped patches of XPax-2 expressing tissues which will contribute to the midbrain-hindbrain boundary flank the midline (arrowhead). Note that staining of XPax-2 can now also be detected in single neurons arranged in stripes on either side of the midline. (E) Lateral view of a stage 21 embryo. XPax-2 expression is associated with the region of the future optic stalk (os) and vesicle, the midbrain-hindbrain boundary (m-h), the otic vesicle (ov) and with cells in the spinal cord (sc). Note also the first appearance of staining in the pronephric anlage (pa). (F) Lateral view of a stage 24 embryo. XPax-2 expression can now also be detected in the furrows of the visceral arches (va), and in both compartments of the developing pronephric kidney, the pronephros (p) and the pronephric duct (pd). XPax-2 expression in the hindbrain (hb) see Fig. 7A ). For PCR amplification, primers XP-26 and XP-15 were chosen to anneal at the translational start site and in the 3′-untranslated region, respectively. Both primers were designed to amplify cDNAs derived from XPax-2a and XPax-2b-encoding transcripts. The resulting cDNA libraries were analyzed systematically with the aim of identifying novel Pax-2 splice variants (see Section 4 for details).
Analysis of a total of 140 cDNA clones containing XPax-2 sequences led to the identification of six novel isoforms which were named XPax-2(4) to XPax-2(9). We determined the DNA sequences of XPax-2 cDNA clones representing each novel XPax-2 isoform class and compared them with the previously isolated XPax-2 isoforms (data not shown). Isoforms XPax-2(4), XPax-2(5) and XPax-2(7) were found to be derived from transcripts of the XPax-2a gene, while XPax-2(8) was from the XPax2b gene. The cDNAs representing isoforms XPax-2(6) and XPax-2(9) were found to be hybrid clones consisting of sequences derived from both XPax-2 genes (see legend to Fig. 4 ). It is likely that these hybrid clones were generated during the PCR amplification process. Evidence for the existence of XPax-2 mRNA species homologous to isoforms XPax-2(6) and XPax-2(9) in Xenopus embryos and pronephric kidneys will be provided later (Fig. 6) .
In general, the generation of alternatively spliced transcripts can be understood based on the exon/intron organization of the corresponding gene. While the exon-intron structures of the two XPax-2 genes are currently not known, the genomic structure for human Pax-2 has been recently reported (Sanyanusin et al., 1996) . Based on sequence comparisons of the Xenopus Pax-2 splice variants with human XPax-2 cDNAs of known exon compositions ( Fig. 1 and data not shown), it appears that the locations of introns have been conserved during evolution and it is likely that amphibia and humans share the same basic exon organization of their Pax-2 genes. Twelve exons have so far been identified in the human Pax-2 gene. The identification of a novel intervening sequence present in XPax-2b(2) and XPax-2a(4) suggests that Xenopus Pax-2 genes are composed of at least 13 exons. Based on this model, the structural organization of all XPax-2 isoforms isolated in this study is presented in Fig. 4 . It appears that the diversity of XPax-2 isoforms is generated by alternative splicing of exons downstream of the DNA-binding paired domain. Exons 1, 2, 3, 4, 10, 12 and 13 were found to be common to all XPax-2 isoforms, while none appeared to contain sequences encoding exon 6. Finally, all described XPax-2 cDNAs retained the original reading frame despite being subject to extensive alternative splicing events.
Alternate use of consensus 3′ splice acceptors generates additional diversity among XPax-2 mRNAs
Canonical 3′ splice acceptor sequences are characterized by an invariant AG dinucleotide at the -2 and -1 positions of the intron, and are usually preceded by a C or U at the -3 position (Stephens and Schneider, 1992) . It has been previously shown that distinct splice forms of Pax mRNAs can be attributed to the use of alternate 3′ splice acceptors (Kozmik et al., 1993; Poleev et al., 1995; Vogan et al., 1996) . DNA sequence comparisons revealed evidence that similar alternative splicing events occur in XPax-2 transcripts. The N-terminus of isoform XPax-2b(8) differed from XPax2b(2) by the absence of three nucleotides, CAG, at the junction of exon 1 and 2 (Fig. 5A) . The observed deletion is most likely due to alternative splicing to an AG acceptor splice site present in exon 2 as illustrated in Fig. 5 . The   Fig. 4 . Schematic representation of Xenopus Pax-2 isoforms generated by alternative splicing. The structure of the Xenopus Pax-2 protein is shown schematically with the corresponding domain organization (PD, paired domain; OP, octapeptide; HD, homeodomain) indicated. The predicted exon structure is based on data from sequence comparisons of Xenopus Pax-2 isoforms (see Fig. 1 ) and on the exon organization of the human Pax-2 gene (Sanyanusin et al., 1996) . The positions of the introns are indicated by arrows. Exons are numbered from 1 to 13. The position of sequences in exons 1, 3, 4, 7, 8, 10 and 13, respectively, used to derive primers for RT-PCR are identified by arrows which are labeled with the name of the primer. Below, cDNAs encoding different splice variants of XPax-2 are drawn diagrammatically. Splice variants XPax-2(1), XPax-2(2) and XPax-2(3) represent full-length cDNAs isolated by screening from a Xenopus head cDNA library. The cDNAs encoding XPax-2(4) to XPax-2(9) were isolated from a cDNA library generated from pronephric kidney RNA. The exon composition of each splice variant is indicated with numbers. The sequenced cDNAs clones were derived from transcripts of the XPax-2a gene in the case of XPax-2(1), XPax-2(3), XPax-2(4), XPax-2(5) and XPax-2(7) and for XPax-2(2) and XPax-2(8) from the XPax-2b gene. For hybrid clone XPax-2(6), exons 1, 2, 3 and 4 were from XPax-2b and exons 7, 8, 10, 11, 12 and 13 of XPax-2a. For hybrid clone XPax-2(9), exons 1, 2, 3, 4 and 10 were derived from the XPax-2a gene, while exons 12 and 13 originated from the XPax-2b gene.
deduced amino acid sequence of predicts that the proline and glycine residues are replaced by a single arginine residue. This splicing event was not unique to , since the exact same CAG trinucleotide was found to be deleted in the cDNA encoding the XPax-2(9) isoform (data not shown). Comparison of the C termini of XPax-2a (7) and XPax-2a(1) revealed that XPax-2a(7) contains an insertion of nine nucleotides located between exon 11 and 12 (Fig. 5B) . The insertion probably represents sequences derived from intron 11. A consensus 3′ splice site at the boundary with exon 12 could be identified. We suggest that the use of a second 3′ splice acceptor flanking the 5′ end of the insertion is responsible for the generation of the insertion. The confirmation of this hypothesis will however have to await sequencing of the exon-intron junctions of the XPax-2 genes. Finally, sequencing of a number of additional XPax-2 cDNA clones revealed the presence of a further consensus 3′ splice sequence present in exon 13 (Fig.  5C ). Use of this site results in the splicing out of a 19-nucleotide sequence of exon 13. This leads to a shift in the reading frame and gives rise to a Pax-2 isoform with distinct C terminus (Fig. 5D ). In summary, our results suggest that differential utilization of consensus 3′ splice acceptor sites present in exons 2 and 13, and presumably in intron 11, generates additional diversity of XPax-2 transcripts.
Temporal regulation of alternative splicing of XPax-2 transcripts in the early Xenopus embryo
We used RT-PCR to address whether expression of XPax-2 isoforms is regulated during Xenopus embryogenesis. For PCR, several sets of primer pairs were selected based on the proposed exon organization of the XPax-2 genes (Fig. 4) . All PCR primers were designed to amplify cDNAs derived from transcripts of both XPax-2 genes. The RT-PCR assay was carried out in conjunction with Southern blotting and hybridization to visualize amplification products encoding XPax-2 sequences. The identity of specific bands was determined in comigration experiments with amplification products of known exon composition ( Fig.  6C,D; and data not shown). In some cases, amplification products were also verified by cloning and DNA sequencing (e.g. products marked by asterisks and filled circles in Fig.  6D ). For a given XPax-2 isoform, the amplification products of the two pseudoallelic forms are of equal size and can therefore not be distinguished in the assay used here. We will therefore not maintain a distinction between the two pseudoallelic XPax-2 genes in describing the exon composition of the observed amplification products. We also want to stress that RT-PCR was performed 'semi-quantitatively' allowing us to assess the presence or absence of specific XPax-2 transcripts rather than determining precise expression levels.
Alternative splicing in the paired domain can dramatically alter the DNA binding affinity of Pax proteins as described for Pax-3, Pax-5 and Pax-6 (Epstein et al., 1994b; Vogan et al., 1996; Zwollo et al., 1997) . To determine whether similar alternative splicing events can occur in the paired domain of XPax-2, we selected for RT-PCR primers XP-25 and XP-31 directed against sequences in exon 1 and exon 3, respectively. All cloned XPax-2 cDNAs contain exons 1, 2 and 3 (see Fig. 4 ), and generate in PCR experiments amplification products of 380 bp (data not shown). RT-PCR experiments using RNA isolated from embryos ranging from unfertilized eggs to stage 34 tadpole embryos consistently resulted in a single amplification product composed of exons 1, 2 and 3 (Fig. 6A) . Evidence for maternal transcripts present in unfertilized eggs and in blas- (Sanyanusin et al., 1996) . (A) XPax-2b(8) contains a threenucleotide deletion within exon 2. The nucleotide and amino acid sequences of XPax-2b(2) are shown below. The nucleotide sequence deleted in XPax-2b(8) is boxed. (B) XPax-2a(7) contains an insertion of nine nucleotides located between exon 12 and 13. The sequence is presumably derived from intron 11 and has a consensus 3′ splice site. For comparison, the equivalent region in XPax-2a (1) Fig. 4) . Total RNA was extracted from unfertilized eggs (E) and embryos of the indicated stages, and assayed for the expression of XPax-2 splice variants by RT-PCR. Amplification products were separated on agarose gels, transferred onto nylon membranes and hybridized with appropriate radiolabeled XPax-2 probes. The migration positions of size standards are shown on the left of the autoradiographs. On the right, selected amplification products are identified by arrowheads. Their exon composition was determined by comparison with XPax-2 cDNAs of known exon composition (autoradiographs on the right of C and D) and by sequencing of the cloned amplification products. The numbering of exons is based on the model in Fig. 4. (A) Alternative splicing in the paired domain region. Primers XP-25 and XP-31 directed against sequences in exon 1 and 3, respectively, were used for the RT-PCR analysis. A single amplification product with a structural organization consisting of exons 1, 2 and 3 was detected. (B) Alternative splicing in the region of the octapeptide motif. Primers XP-59 and XP-11 are directed against sequences in exon 4 and 7, respectively. The autoradiograph displays the temporal expression profile of alternatively spliced XPax-2 transcripts in the early embryo. (C) Alternative splicing between exons 4 and 10. Primers XP-59 and XP-63 are used for PCR amplification. The autoradiograph on the left displays the spectrum of alternative splice variants in the developing embryo. The autoradiograph on the right compares the amplification products generated with XPax-2 cDNA templates of defined exon composition to those detected in the developing embryo. (D) Alternative splicing in the C-terminal region. Primers XP-9 and XP-24 are directed against sequences in exon 8 and 13, respectively. The autoradiograph on the left displays the spectrum of alternative splice variants in the developing embryo. Amplification products generated by alternate use of 3′ splice acceptors present in intron 11 or exon 13 are marked by asterisks or filled circles, respectively. The autoradiograph on the right compares the amplification products generated with XPax-2 cDNA templates of defined exon composition to those detected in the developing embryo. (E) Control for equal RNA amounts. RT-PCR experiments were carried out in parallel with ornithine decarboxylase (ODC) specific primer pair ODC-1/ODC-2. Amplification products were separated by agarose gel electrophoresis and visualized by staining with ethidium bromide. M, lane with size markers. tula stage embryos was obtained upon overexposure of the blot (data not shown). The vast majority of XPax-2 transcripts were however detected in embryos from stage 12 on with expression levels remaining essential constant throughout the embryonic stages tested (Fig. 6A) . These observations are consistent with our in situ hybridization studies, which place the onset of spatially localized XPax-2 transcription to mid-gastrula stages (Fig. 3) .
The next set of PCR primers was chosen to investigate alternative splice events in the region of the octapeptide motif. In particular, we were interested in investigating whether we could detect XPax-2 transcripts containing the predicted exon 6, for which evidence exists in zebrafish, mouse and human Krauss et al., 1991; Sanyanusin et al., 1996) . Primers XP-59 and XP-11 were designed to recognize sequences within exon 4 and exon 7, respectively (Fig. 4) . RT-PCR experiments allowed us to identify two amplification products (Fig. 6B) . The larger amplification product was shown to consist of exons 4, 5, and 7, while the smaller one contained exons 4 and 7 (data not shown). Both amplification products could not be detect in pre-gastrula embryos, but were present in embryos from stage 12 on. Together with evidence presented below (Fig. 6D ), it appears that XPax-2 transcripts composed of exon 6 are not expressed during early Xenopus embryogenesis.
The exons 4 and 10 are common to all XPax-2 cDNAs described in this study (Fig. 4) . We therefore chose primers XP-59 and XP-63 to investigate splicing between these exons. The RT-PCR reactions revealed at least eight distinct XPax-2 bands and for five of the eight amplification products the exon composition was determined ( Fig. 6C ; and data not shown). None of the amplification products appears to contain exon 6. The majority of the amplification products were detected in gastrula stage and older embryos. Two amplification products, however, were detected also in pre-gastrula embryos. They were found to be composed of exons 4 and 10, and exons 4, 5, and 10, respectively. Evidence for maternal expression of XPax-2 transcripts had also been found with primers annealing to exons 1 and 3, respectively (see legend to Fig. 6A ). We conclude that maternal transcripts of XPax-2 contain either exons 1, 2, 3, 4 and 10 or exons 1, 2, 3, 4, 5 and 10. Only isoforms XPax-2(7), XPax-2(8) and XPax-2(9) have exon compositions consistent with maternal mRNA expression. Further, XPax-2 isoforms (1) to (6) are expressed exclusively as zygotic mRNAs in the early Xenopus embryo.
The different XPax-2 isoforms diverge mainly in their Cterminal domains indicating that this region is possibly most susceptible to alternative splice events. We therefore selected primers XP-9 and XP-24 to investigate how alternative splicing affects the C-terminal domain between exon 8 and 13 (Fig. 4) . This primer pair will detect only expression of strictly zygotic XPax-2 mRNAs. RT-PCR experiments revealed a complex pattern of amplification products ranging in size from 270 to 580 bp (Fig. 6D ). Amplification products with exon compositions corresponding to cloned XPax-2 isoforms were readily identified (Fig. 6D, right  panel) . Two minor bands (identified by asterisks and filled circles in Fig. 6D ) were found to be flanking the amplification products containing exons 8, 10, 11, 12 and 13 and exons 8, 10, 12 and 13. We demonstrated by cloning and DNA sequencing that they represent transcripts generated by the alternate use of consensus 3′ splice sites present in intron 11 and exon 13, respectively, as described earlier (see Fig. 5B,C) . None of the amplification products were detected before mid-gastrula stages indicating that isoforms XPax-2(1) to XPax-2(6) are not expressed as maternal transcripts. Most of the detected amplification products are not subject to significant regulation of expression levels between gastrula stages and stage 34. The largest amplification product comprising of all exons from 8 to 13 represents an exception, since it is predominantly detected in gastrula and neurula stage embryos. In summary, we have been able to define two classes of XPax-2 mRNAs. A first group consisting of strictly zygotic XPax-2 mRNAs and second one comprised of those transcripts which display, in addition, maternal expression.
Expression of XPax-2 splice variants in the developing pronephric kidney
Isoforms XPax-2(1) to (3) were identified in a cDNA library prepared from heads of stage 28-30 embryos, while XPax-2(4) to (9) were isolated from cDNA libraries of stage 24 pronephric explants. The question therefore arises whether expression of specific XPax-2 isoforms is restricted to the developing pronephric kidney. We employed the RT-PCR approach now using RNA prepared from embryos dissected into heads and explants enriched for pronephroi. Two embryonic stages were chosen for the dissections with the purpose of representing an early (st. 24) as well as an advanced stage (st. 36) of pronephric kidney development. Particular care was taken to assure that pronephric explants were not contaminated with neural tissues (e.g. spinal cord). Head explants contained most of the XPax-2 expressing tissues with the exception of spinal cord and pronephric kidneys (Fig. 7A) .
We carried out RT-PCR experiments using primers XP-59 and XP-63 to monitor splicing events between exons 4 and 10, which are found in all described XPax-2 isoforms. Using cDNAs from pronephric kidney explants as templates, we were able to detect at least eight distinct amplification products (Fig. 7B) . The exon composition of five bands could be assigned. They represent the most abundant amplification products. Three amplification products remain currently uncharacterized. In most cases, the expression levels of the amplification products did not change between stage 24 and stage 36 pronephroi. Interestingly, the profiles of amplification products observed with cDNAs from pronephric explants were essentially identical to those obtained with cDNAs from heads with the exception of an amplifica-tion product composed of exon 4 and 10. This band was found predominantly in older pronephroi, but longer exposures of the blot revealed faint signals in stage 24 pronephroi and in head explants of both embryonic stages (data not shown). To control for equal amounts of RNA in cDNA synthesis reactions, the expression of commonly used control genes such as ornithine decarboxylase (ODC), elongation factor 1a (EF-1a), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or histone H4 was monitored. We found that all of these genes were suitable standards, if the RNA preparation originated from embryonic heads. However, if RNA was obtained from pronephric kidney explants, expression of control genes was either not detectable (ODC, EF-1a, and GAPDH; data not shown) or in the case of histone H4 was found to be at lower levels than expected (Fig. 7D ). Similar observations have been reported previously, e.g. for cells of the thyroid (Savonet et al., 1997) . We therefore believe that in the absence of a better standard the spectophotometric measurement of total RNA for pronephric tissues represents the only reliable method of quantification. Taken together, our experiments have so far indicated that splicing of XPax-2 transcripts generates in the pronephric kidney a similar spectrum of isoforms as seen in head explants. Indeed, the expression profiles were found to be indistinguishable to those obtained with cDNAs from whole embryos of the corresponding stages (compare with Fig. 6D) .
In a separate set of RT-PCR experiments, we also used primers to sequences in exons 8 and 13 located in the C-terminal domain of XPax-2. As shown in Fig. 6C , amplification products for all XPax-2 isoforms were present in both tissues analyzed. In younger pronephroi, the expression levels of amplification products containing exon 9 were found to be rather low. Higher levels of amplification products containing exon 9 were however detected in older pronephroi, and the presence of XPax-2 transcripts in pronephric kidney was also confirmed by in situ hybridization using a probe consisting solely of exon 9 (data not shown). Finally, we also carried out RT-PCR experiments using primers XP-59 (exon 4) and XP-24 (exon 13). Again, we could not discern any clear difference between XPax-2 isoforms expressed in the head or the pronephric kidney (data not shown). In summary, the evidence presented here argues strongly against the expression of a unique complement of XPax-2 splice variants in the developing pronephric kidney. We cannot however excluded the possibility that the relative abundance of splice variants might vary during pronephric kidney development.
Induction of XPax-2 transcription in animal cap explants by growth factors
In Xenopus, animal cap cultures represent a convenient way to induce different tissues types in vitro (Asashima, 1994; Dawid, 1994; Kessler and Melton, 1994; Slack, 1994) . For example, the growth factor activin can induce animal cap explants to differentiate in a dose-dependent manner into neural tissue and almost all mesodermal tissues. On the other hand, treatment with basic fibroblast growth factor (bFGF) promotes mainly mesoderm of ventrolateral type. Retinoic acid by itself does not induce mesoderm in animal cap explants, but it can, if added in combination with activin, promote the induction of pronephric tubules at a very high frequency (Moriya et al., 1993; Uochi and Asashima, 1996) . We therefore decided to investigate the regulation of XPax-2 expression and alternative splicing under in vitro conditions in animal cap cultures.
Animal caps were excised from stage 8-9 embryos, and treated with either activin, bFGF, retinoic acid, or a combination of activin and retinoic acid. When control embryos reached stage 28, the caps were analyzed for the expression of XPax-2 by RT-PCR as well as by whole mount in situ hybridization (Fig. 8) . Untreated animal caps or caps incubated with retinoic acid alone were unable to activate XPax-2 gene transcription as illustrated in RT-PCR experiments using primers pairs XP-59/XP-63 and XP-9/XP-24, respectively (Fig. 8A,B) . Strong induction of XPax-2 transcription was seen in the presence of activin, while bFGF was found to be a much less potent inducer. The profile of amplification products was however very similar for both growth factors and mirrored the situation described earlier for whole embryos (compare Fig. 8A,B with Fig. 6C,D) . Interestingly, the inclusion of retinoic acid in the activintreated cultures neither changed the pattern nor the extent of XPax-2 splicing (Fig. 8A,B) . The induction of Pax-2 transcripts in animal cap cultures could also be confirmed by in situ hybridization (Fig. 8D) . Animal caps responded to activin by extensive elongation and displayed patches of strong XPax-2 staining. Retinoic acid, in combination with activin, significantly suppressed the elongation process, but still allowed expression of XPax-2 transcripts. Despite the fact that all treatments used here have been described to induce different spectra of tissues in animal caps (Green et al., 1990; Moriya et al., 1993; Uochi and Asashima, 1996) , we were unable to detect significant differences in the splicing of XPax-2 transcripts. Based on our in vivo and in vitro experiments, we conclude that splicing of XPax-2 transcripts is not regulated in a tissue-specific manner during early Xenopus embryogenesis.
Discussion
The simple organization together with its role as an inducer of the mesonephric and metanephric kidney makes the pronephric kidney attractive for studies on the molecular and cellular mechanisms that control kidney organogenesis. In the present study, we report the isolation and characterization of cDNAs for Pax-2, a possible regulator of early kidney organogenesis, from the frog Xenopus laevis. We found that XPax-2 gene expression is associated with all epithelial structures of the developing pronephric kidney from the onset of morphogenesis. During this developmental process, XPax-2 transcripts are extensively spliced as illustrated by the isolation of cDNAs encoding multiple novel Pax-2 isoforms from pronephric kidney libraries. An analysis of XPax-2 transcripts from pronephroi and other embryonic tissues revealed that alternative splicing was not regulated in a tissue-specific manner. The implications of our findings will be discussed below.
Evolution and genomic organization of vertebrate class III Pax genes
Three genes, Pax-2, Pax-5 and Pax-8, comprise currently the class III Pax gene family in vertebrates (Walther et al., 1991; Noll, 1993; Nornes et al., 1996) . Class III Pax genes arose by two independent gene duplications from a common ancestral gene (Noll, 1993) . Based on sequence homologies and phylogenetic tree analysis, it is believed that a first duplication event produced Pax-8 and an ancestor gene with properties of both Pax-2 and Pax-5. A second, more recent duplication event generated Pax-2 and Pax-5. Both duplication events apparently occurred in the course of vertebrate evolution after the separation of the lines leading to fish and higher vertebrates (Noll, 1993) . Supporting this hypothesis, zebrafish Pax-2 (previously referred to as Pax-B or pax [zf-b] ) represents the only class III Pax gene identified in fish so far. The complexity of the class III Pax gene family in amphibians was not known up to now. The Pax cDNAs isolated in this study were shown clearly by sequence comparison and expression pattern to be Xenopus homologues of mammalian Pax-2 genes. In addition, we have also isolated cDNAs encoding a Xenopus Pax-5 homologue (N. Heller and A.W. Brändli; unpublished data). We currently lack evidence for the existence of Xenopus Pax-8 homologue. Since the duplication event that generated Pax-2 and Pax-5 is considered to be the evolutionary younger event, the possibility exists that the Xenopus genome might also harbor Pax-8 genes. We therefore believe Fig. 8 . Induction of XPax-2 splice variants in animal cap explants. Embryos were cultured until stage 8-9, at which the upper part of the animal hemisphere (animal cap) was removed. The animal caps were treated for 12 h at 22°C with either activin (10 ng/ml), retinoic acid (RA, 10 mM), basic FGF (bFGF; 100 ng/ml) or a combination of activin and RA. Control explants were cultured in the absence of any factors. Expression of XPax-2 splice variants was assayed that the currently known complexity of class III Pax genes was established before the separation of amphibians and higher vertebrates in evolution.
The common evolutionary origin of the class III Pax genes is also reflected in their genomic organization. All the known intron positions are strictly conserved between human Pax-2, Pax-5 and Pax-8 (Kozmik et al., 1993; Poleev et al., 1995; Busslinger et al., 1996; Sanyanusin et al., 1996) . Although the genomic organization of the Xenopus Pax-2 genes are currently not known, the evidence from our studies on alternative splicing of XPax-2 transcripts are consistent with this notion. For example, sequence comparisons revealed that XPax-2a(1) and XPax-2a(3) represent Xenopus homologues of previously reported human Pax-2 splice variants (Fig. 1B) . Furthermore, all XPax-2 isoforms reported here can be explained using the exon organization of the human Pax-2 gene as a paradigm (Fig. 4) .
Two cDNAs, XPax-2b(2) and XPax-2a(4), are generated by inclusion of a novel intervening sequence (Figs. 1B, 4) . Interestingly, the human Pax-8 gene contains a homologous sequence encoded by an alternatively spliced exon (identified as exon 8 (Poleev et al., 1995) or exon 9 (Kozmik et al., 1993) , respectively). It is therefore likely that the novel XPax-2 intervening sequence is also encoded by an exon, which would represent a novel vertebrate Pax-2 exon. Based on this observation, we propose that the coding sequences of the Xenopus Pax-2 can be composed of up to 13 exons (Fig.  4) . We have so far been able to obtain nucleotide sequence information on all exons, but exon 6. Isolation of genomic clones of XPax-2 should resolve this remaining open question.
Pax genes in visceral arch development
Analysis of XPax-2 expression during Xenopus embryogenesis revealed that transcripts were associated with the developing nervous system, sensory organs and the excretory system (Fig. 3) . This expression pattern is essentially identical to that reported for Pax-2 homologues in zebrafish (Krauss et al., 1991; Mikkola et al., 1992; Püschel et al., 1992) and mice Nornes et al., 1990; Püschel et al., 1992) and indicates that the mechanisms controlling tissue-specific regulation of Pax-2 gene expression have been conserved during vertebrate evolution. In addition, we identified Pax-2 expression in the ectodermally derived furrows of the visceral arches (Fig. 3N) . This novel site of Pax-2 expression has possibly been overseen in previous studies of zebrafish and mouse embryos.
What could be the role of Pax-2 in visceral arch development of the vertebrate embryo? In water-living embryos of lower vertebrates, the furrows and pouches of the visceral arches fuse to form the visceral clefts or gill slits. It is conceivable that Pax-2 could be have a role in this process by regulating the fusion process. Other morphogenetic processes leading to fusion processes, such as optic fissure and neural tube closure, have been shown in the past to depend on Pax-2 gene function (Favor et al., 1996; Torres et al., 1996) . In the mammalian embryo, only the first furrow gives rise to a recognizable structure (Carlson, 1996) . It persists as the outer ear, while the other furrows are overgrown. The tympanic membrane (or eardrum) is formed where the first furrow meets the first pharyngeal pouch. By extension, Pax-2 could be necessary for some aspects of ear development in the mammalian embryo. Recent studies of mouse mutants have shown that Pax-2 is required for the development of the auditory system in the inner ear (Torres et al., 1996) . Whether a lack of Pax-2 expression also affects the morphogenesis of the outer ear or the formation of the tympanic membrane remains to be established.
Expression of XPax-2 in the developing pronephric kidney
We have demonstrated that XPax-2 expression is associated with developing pronephric kidney (Fig. 3) . How does its expression correlate with the major events of organogenesis: induction, determination, morphogenesis and differentiation? The timepoint at which pronephric kidney induction occurs in the amphibian embryo is unknown, but the prospective pronephric area has been mapped in gastrulating embryos to a region of the marginal zone ventrolateral to the blastopore (Pasteels, 1942) . Determination occurs by the midneurula stage, when the prospective pronephric area will form pronephric tubules, even when transplanted to heterotopic sites (Fales, 1935) . As morphologically distinguishable structure, the pronephric anlage becomes first apparent with the completion of neurulation. In Xenopus embryos, it appears as a homogenous bulge in the mesoderm directly ventral to the somites at approximately embryonic stage 21, which correlates precisely with the first detectable expression of XPax-2 (Fig. 3E) . The timing of XPax-2 expression makes it therefore rather unlikely that XPax-2 has a central role in the determination process, but rather suggests a role in pronephric kidney morphogenesis and/or differentiation. This view is supported by studies in zebrafish and mice deficient for Pax-2, where the earliest defects in the excretory system are associated with the elongation of the pronephric duct (Brand et al., 1996; Favor et al., 1996; Torres et al., 1995) .
A poorly understood aspect of pronephric kidney development is the contribution of the rectal diverticulum to the formation of the excretory canal. In the tailbud stage Xenopus embryo, a pair of rectal diverticuli form by evagination from the dorsal wall of the proctodaeum. They elongate in the anterior direction to fuse with the posterior growing pronephric ducts. XPax-2 was found to be expressed in both the proctodaeum and the extending rectal diverticuli, demonstrating unequivocally their contribution to the establishment of the excretory canal (Fig. 3G-J) . To our knowledge, XPax-2 represents the first molecular marker found to be expressed in the rectal diverticuli.
Alternative splicing of class III Pax gene transcripts
The cloning of Pax-2 cDNAs from zebrafish (Krauss et al., 1991) , mouse and human (Eccles et al., 1992; Ward et al., 1994; Sanyanusin et al., 1996) had led to the identification of three Pax-2 splice isoforms. In Xenopus, we have isolated through screening of head and pronephric kidney cDNA libraries clones for nine distinct isoforms (Fig. 4) . Two of these isoforms, XPax-2a(1) and XPax-2a(3), were homologous to previously identified mammalian isoforms. Thus, alternative splicing of Pax-2 transcripts apparently generates at least ten distinct vertebrate Pax-2 isoforms. We believe that the number of expressed splice variants generated in vivo is in fact even higher. For one, the exon compositions of a number of amplification products are still unknown (see Fig. 6B,C) . For the other, we have provided evidence that the diversity of Pax-2 transcripts is further increased by through alternate use of consensus 3′ splice acceptors (Fig. 5) . These alternative splicing events can either lead to small deletions or insertions of one to three amino acids residues, while still preserving the original reading frame, as observed with XPax-2b(8) and XPax-2a(7). In the case where exon 13 is affected, splicing can even generate Pax-2 isoform with an alternative C-terminus (Fig. 5C,D) . A Pax-2 isoform with an alternative C-terminal domain has been previously also reported for human Pax-2 (Ward et al., 1994) . Transcripts of the related Pax-5 and Pax-8 genes are also modified by alternative splicing. For Pax-5, transcription from two distinct promoters results in splicing of two alternative 5′ exons, exon 1a and exon 1b, to the common coding sequence . In addition, three novel splice forms have been recently found to be expressed during B-cell development (Zwollo et al., 1997) . For the Pax-8, a total of seven splice variants have been identified (Poleev et al., 1992; Kozmik et al., 1993) . Alternative splicing of class III Pax gene transcripts is therefore not uncommon, but our studies have revealed that XPax-2 transcripts are subjected to a degree of alternative splicing that had previously not been anticipated.
Functional implications of Pax-2 splicing
Transcripts that either contain or lack particular exons may have entirely different functions at the protein level (Foulkes and Sassone-Corsi, 1992; McKeown, 1992) . Pax proteins are thought to function as transcription factors by being able to bind to specific DNA elements of target genes and to act as transcriptional activators. Alternative splicing has been found to affect both aspects of Pax protein function. Introduction of an additional exon into the paired domain of Pax-6 modifies the structure and DNA-binding properties of the protein (Epstein et al., 1994b) , while deletion of an exon in the Pax-5 paired domain abolishes DNA binding completely (Zwollo et al., 1997 ). An alternative mechanism has been described for  where alternate use of consensus 3′ splice sites results in the removal of a single glutamine residue generating isoforms with increased affinity to target DNA sequences (Vogan et al., 1996) . Structural motifs mediating transactivation are located in the C-terminal domain of Pax proteins, a region that is preferentially modified by alternative splicing. For Pax-8, several isoforms carrying alternative C termini have been described to harbor distinct transactivation abilities (Kozmik et al., 1993; Poleev et al., 1995; . Similar results were recently reported for isoforms of Pax-9 (Nornes et al., 1996) .
How does alternative splicing modulate the function of Pax-2 isoforms? Due to the limited number of Pax-2 variants described so far, the consequences of Pax-2 splicing on protein function are poorly understood. Following predictions can however be made. Exons 1 to 4 of vertebrate Pax-2 transcripts encode the paired domain, which is sufficient to mediate DNA binding (Fickenscher et al., 1993; Epstein et al., 1994a) . Since these exons are also present in all XPax-2 isoforms, it is very likely that all will be able to bind target sequences. The 3-nucleotide deletion found in exon 2 of XPax-2(8) and XPax-2(9) might, however, modify the DNA binding characteristics as has been described recently for Pax-3 and Pax-7 (Vogan et al., 1996) . The highly conserved octapeptide sequence is encoded by exon 5 and appears to act as a repressor of the activation potential . Interestingly, XPax-2(5), XPax-2(6) and XPax-2(9) represent naturally occurring variants lacking exon 5 and could therefore be more potent transactivators in vivo. Comparable transactivation properties were reported for the two Pax-2 isoforms which differ by containing or lacking exon 6 (Kozmik et al., 1993; Lechner and Dressler, 1996) . We were unable to detect XPax-2 transcripts carrying sequences related to exon 6 (Fig. 6B ), although such transcripts have been described in zebrafish, mouse and humans Eccles et al., 1992; Krauss et al., 1992; Sanyanusin et al., 1996) . It is possible that the expression of exon 6 containing XPax-2 transcripts is developmentally regulated in Xenopus, and occurs only in advanced embryos or in adult animals which were not analyzed in this study. Alternatively, mutations inactivating correct splicing of exon 6 might have occurred during the evolution of Xenopus laevis. In the light of the apparent lack of functional significance of exon 6, such mutations might not pose a selective disadvantage for carriers of the mutations. Proof whether such mutations occurred indeed will have to await cloning of the XPax-2 genes. The role of the partial homeodomain motif, found in all class III Pax genes, has so far not been determined. XPax-2(7), XPax-2(8) and XPax-2(9) were found to lack the homeodomain encoded by exon 7 and might therefore represent useful tools to resolve this question. Finally, alternative splice events in the C-terminal domain of Pax-2 can generate isoforms which in vitro confer differential regulation of the human WT-1 promotor (McConnell et al., 1997) . The transcriptional competence appears also to be regulated by a regulatory module composed of activating and inhibitory sequences located at the C-terminal end of all class III Pax proteins (Dörfler and Busslinger, 1996) . For XPax-2 isoforms, the presence or absence of exon 11 represents the only splice event observed in this region. Inclusion of exon 11 would extend the transactivation domain defined by Dörfler and Busslinger (1996) and could modulate the transactivating properties of the described regulatory module. In summary, the nine distinct Pax-2 cDNAs isolated in this study can be considered as an unique collection of variants generated by in vivo 'deletion mutagenesis'. Testing their DNA binding and transactivation action properties will complement previous structure-function studies carried out with in vitro mutagenized Pax-2 proteins (Dörfler and Busslinger, 1996; Lechner and Dressler, 1996) .
Developmental regulation of Pax-2 splicing
For transcription factors, developmental regulation of alternative splicing is a widespread phenomenon, but the biological consequences are understood in only a very few cases (López, 1995) . A number of recent studies have demonstrated that alternative spliced products of Pax-8 are not only temporally, but also spatially regulated during embryogenesis (Kozmik et al., 1993; Poleev et al., 1992 Poleev et al., , 1995 . Two previous studies using nuclease protection assays had failed to detect any temporal nor spatial regulation of Pax-2 splicing (Dressler and Douglass, 1992; Fickenscher et al., 1993) . The probes used in these studies span only a limited amount of the coding sequence and were chosen with the intention to discriminate between the two only Pax-2 splice variants known at the time. Many of the limitations inherent to nuclease protection assays have been overcome by the PCR-based methodology used in this study. In particular, we are now able to display the entire spectrum of splice variants within the experimental boundaries defined by the PCR primers used. We therefore reinvestigated comprehensively the question of developmental regulation of Pax-2 splicing by analysis of whole embryos, explants of enriched pronephric tissues and in vitro generated tissues. Our studies on whole embryos clearly established that alternative splicing of XPax-2 transcripts is under temporal control during embryogenesis (Fig. 6) . A limited number of XPax-2 transcripts represented by XPax-2(7), XPax-2(8) and XPax-2(9) were found to be expressed already as maternal transcripts in the pre-gastrula embryo. These maternal isoforms are characterized by the lack exons 6, 7, 8 and 9. They however still contain the minimal structural elements to mediate DNA binding and transactivation properties. The functional significance of maternal Pax-2 transcripts is unclear, especially since Pax-2 function is not necessary for gastrulation (Torres et al., 1995 (Torres et al., , 1996 Brand et al., 1996; Favor et al., 1996) . The completion of gastrulation is marked by a sudden burst of XPax-2 gene expression. At this time point, the complete range of XPax-2 splice variants can already be detected (Fig. 6) . In situ hybridization identifies the future midbrain-hindbrain boundary as the only source of XPax-2 gene expression at this developmental stage (Fig. 3A,B) . This observation suggests that a single tissue can generate the full spectrum of Pax-2 isoforms. We then focused our attention to the developing pronephric kidney. Explants enriched for pronephroi as well as in vitro generated pronephric tissues were examined to determine the extent of XPax-2 isoform expression in this organ (Figs. 7 and 8) . The results presented in this study clearly demonstrate that pronephric kidneys express the complete set of XPax-2 isoforms and that there is little variation in the relative abundance of transcripts during pronephric kidney organogenesis. A similar apparent lack of tissue-specific regulation of alternative splicing is also seen with Pax-3, Pax-6 and Pax-7 (Epstein et al., 1994b; Vogan et al., 1996) . The analysis was however limited to single splice events as in previous studies addressing Pax-2 splicing (Dressler and Douglass, 1992; Fickenscher et al., 1993) . In the present study, we demonstrate now for pronephroi that the absence of tissue-specificity extents to all splice events for Pax-2. It is therefore rather unlikely that certain isoforms of Pax-2 could have tissue-or organ-specific functions. Our findings rather suggest that alternative splicing may simply serve to increase the functional diversity of Pax-2 genes during embryogenesis. Further characterization of the Pax-2 splice variants will now allow us to design experiments in which the expression levels of different isoforms in Xenopus embryos and in growth factortreated animal cap cultures will be altered. Ultimately, we hope to achieve a better understanding of how the different Pax-2 isoforms function in establishing and controlling the inductive cascades of events necessary for kidney organogenesis.
Materials and methods
Growth factors and retinoic acid
Recombinant Xenopus basic FGF (bFGF) was prepared from E. coli strain XF140 using a T7 expression system essentially as described (Kimelman et al., 1988 ). An additional ion-exchange chromatography step was added to the protocol. In brief, the cleared bacterial lysate was adjusted to 0.1 M sodium phosphate (pH 6.0), and loaded onto a 80-ml CM Sephadex C25 column (Pharmacia Biotech). The column was washed with 0.1 M sodium phosphate (pH 6.0), and then with 0.1 M sodium phosphate, 0.1 M NaCl (pH 6.0). The bound protein was eluted with 0.1 M sodium phosphate, 0.4 M NaCl (pH 6.0). Peak fractions were collected, pooled and applied to a 5-ml HiTrap heparin column (Pharmacia Biotech). The column was washed first with 0.6 M NaCl, 10 mM Hepes (pH 7.2) and then with 1 M NaCl, 10 mM Hepes (pH 7.2). The bound protein was eluted with 2 M NaCl, 10 mM Hepes (pH 7.2). The eluates were concentrated to 10 mg/ml and the buffer was exchanged with 10 M Tris-HCl (pH 7.0) using Centriprep-10 concentration devices (Millipore). The purity of each preparation was assessed by SDS-polyacrylamide electrophoresis. Only preparations consisting of a single 17 kDa band were used. For animal cap experiments, purified Xenopus bFGF preparations were diluted with 0.5× MMR (1× MMR: 100 mM NaCl; 2 mM KCl; 2 mM CaCl 2 ; 1 mM MgSO 4 ; 1 mM EDTA; 5 mM Hepes (pH 7.4)) containing 1 mg/ml bovine serum albumin (BSA) to a concentration of 10 mg/ml and stored at −80°C. Each preparation was also tested in animal cap assays for bioactivity (Kimelman et al., 1988) . Xenopus bFGF was usually used at 100 ng/ml.
Recombinant human activin A was kindly provided by Kristin Verschueren and Danny Huylebroeck (Laboratory of Molecular Biology, University of Leuven, Leuven, Belgium). Activin A was dissolved in 0.5× MMR containing 1 mg/ml BSA to a concentration of 1 mg/ml and stored at −80°C. The bioactivity of the activin A preparation was tested by serial dilution using the animal cap assay. A working concentration of 5-10 ng/ml was found to give a robust induction as determined by massive elongation of the animal cap explants.
All-trans retinoic acid (Sigma, R-2625) was dissolved in dimethylsulfoxide (DMSO) at 10 mM under dim light. Aliquots were stored at −80°C. Retinoic acid was used at a concentration of 10 mM (Moriya et al., 1993) .
Embryo collection and microdissections
Pigmented Xenopus laevis frogs were purchased from the African Reptile Park (Tokai, South Africa), and albinos from Dr. Charles Thiébaud (Station de Zoologie Expérimentale, Université de Genève, Chêne-Bougeries, Switzerland). Xenopus embryos were obtained by in vitro fertilization as previously described (Newport and Kirschner, 1982; Brändli and Kirschner, 1995) . Embryos were staged according to (Nieuwkoop and Faber, 1956) .
All embryo dissections were performed in 1× MMR. Embryos were raised to stage 24 and 36 for dissection of heads and pronephric explants. Embryos were anesthetized in 1× MMR containing 0.1% tricaine (ethyl-3-aminobenzoate methansulfonic acid; Sigma, A-5040). Dissections were done using a microdissecting knife and watch-makers forceps (Fine Science Tools). First, the heads were cut immediately posterior to the visceral arches. Then, explants enriched for pronephroi ('pronephric explants') were obtained by placing a horizontal cut just below the somites to separate dorsal structures (notochord, somites and neural tube) from ventrolateral tissues (pronephroi, ventral mesoderm, endoderm). Heads and pronephric explants were frozen in liquid nitrogen for later isolation of RNA. See also Fig. 7A , for an outline of the dissection strategy.
Animal cap assays
Animal caps were isolated from stage 8-9 embryos using watch-makers forceps (Dumont No. 5; Fine Science Tools), eye-brow knives and hair loops. The area of dissection was limited to the upper portion of the animal hemisphere, corresponding to roughly one-fourth of the embryo. Care was taken to avoid any marginal zone cells, or large, vegetal cells. Explants were cultured in 0.5× MMR containing 1 mg/ml BSA (Sigma, A-3350). Purified growth factors (Xenopus bFGF or human activin A) and retinoic acid were added at the desired concentrations. Animal caps were incubated in the dark at 22°C for 12 h, after which they were rinsed and transferred to 0.5× MMR/BSA. Animal caps were cultured until control embryos reached stage 28. For further analysis, animal caps were either frozen in liquid nitrogen for later isolation of RNA or fixed for whole mount in situ hybridization.
Isolation of XPax-2 cDNAs by library screening
Partial DNA sequences of Xenopus Pax-2 were isolated by the reverse transcription-polymerase chain reaction (RT-PCR) using degenerate primers. The following degenerate primer pair was used (see Section 4.8 for sequences): XP-1 coding for the target peptide RQRIVE; XP-2 coding for G(V/I)CDN(D/E). EcoRI and XbaI restriction sites were added to the sense and antisense primers, respectively, for convenient ligation. Complementary DNAs (cDNAs) were synthesized from 5 mg of total RNA isolated from stage 21, 24 and 30 Xenopus embryos, respectively, using 500 units of Molony murine leukemia virus reverse transcriptase (Superscript II, GIBCO BRL) and 200 pmol of degenerate primer XP-2 in a total volume of 50 ml. One-twentieth of the cDNA preparation was used as a template for amplification of Pax sequences. PCR was performed in a final volume of 50 ml containing 10 mM Tris (pH 8.3), 50 mM KCl, 2 mM MgCl 2 , 0.01% gelatin, 0.2 mM dNTPs, 100 pmol of each primer (XP-1 and XP-2), and 2.5 units of Taq DNA polymerase (Perkin-Elmer). The amplification parameters were 94°C for 1 min, 50°C for 1 min, and 72°C for 1 min for 35 cycles followed by 10 min at 72°C. One-third of the amplification products were size fractionated on a 4% NuSieve 3:1 agarose (FMC BioProducts) gel. Amplification products of the expected size,~280 bp, were excised, and purified using Geneclean Spin kit (BIO 101). The recovered amplification products were digested with EcoRI and XbaI, repurified and cloned into pBluescript II SK+ vectors (Stratagene). Competent E. coli DH5a bacteria (MAX efficiency, Gibco) were used for transformation. The three cDNAs libraries (st. 21, 24 and 30) were screened for clones with sequences homologous to Pax-2. Altogether 88 cDNA clones were analyzed by restriction fragment mapping and DNA sequencing as described (Brändli and Kirschner, 1995) . DNA sequences were determined from alkaline lysis miniprep DNA using the dideoxy chain termination method (Sequenase version 2.0, Amersham).
Amplification products encoding XPax-2a and XPax-2b were used to screen a Xenopus stage 28-30 head cDNA library (Hemmati-Brivanlou et al., 1991) ligated into an excisable lZAPII vector (kindly provided by Richard Harland, University of California at Berkeley). Fragments were radiolabeled with [ 32 P]dCTP (Amersham) by random priming (Oligolabelling Kit, Pharmacia Biotech), and purified on NUCTRAP push columns (Stratagene). Library screening was carried out under conditions of high stringency (Maniatis et al., 1989) . Positive clones were purified, and converted to Bluescript plasmids using the Rapid Excision Kit (Stratagene) according to the manufacturer's recommendations. Plasmids were analyzed by restriction fragment mapping and DNA sequencing. Three cDNA classes were identified, and the longest cDNAs (2.0 kb for XPax-2a(1), 3.0 kb for XPax-2a(3), and 2.7 kb for XPax-2b(2)) were sequenced. The EMBL Nucleotide Sequence Database accession numbers can be found at the end of Section 4.5.
Isolation of XPax-2 cDNAs by PCR amplification
Sequences common to both XPax-2 genes were chosen to synthesize oligonucleotide primers with the aim of amplifying by PCR the entire open reading frame of XPax-2 cDNAs. Primer XP-26 corresponds to nucleotides in exon 1 starting at the first translational start site. Primer XP-15 is complimentary to sequences in the 3′-untranslated region of exon 13. Sequences of primers are listed in Section 4.8. Nucleotide sequences encoding EcoRI and XbaI restriction sites were added to the 5′-ends of XP-26 and XP-15, respectively. Xenopus explants enriched for pronephroi were microdissected from stage 24 embryos (see Section 4.2. and Fig. 7A ) and used for isolation of total RNA (see Section 4.6). First strand cDNA was generated essential as described (see Section 4.4.) using 0.2 pmol of the antisense primer XP-15 and 10 mg of total RNA. PCR amplification was carried out with the Expand High Fidelity PCR system (Boehringer Mannheim) using one-fortieth of the cDNA preparation as a template. The resulting amplification products were separated by electrophoresis on a 1% agarose gel. A section of the gel containing amplification products ranging between 0.7 and 1.8 kb in size was isolated, and cut into eight slices containing products of increasing size. For each slice, DNA was purified, enriched by a second round of PCR amplification and cloned into the pBluescript II SK (+). From the eight PCR-generated cDNA libraries, a total of 140 cDNA clones were selected and further analyzed by PCR. PCR reactions using different sets of primer pairs were performed to determine the exon composition of each cDNA. Clones representing novel splice variants of XPax-2 were confirmed by sequencing the entire cDNA.
The nucleotide sequences of all XPax-2 cDNAs were submitted to the EMBL Nucleotide Sequence Database, and the accession numbers are as follows: Y10119 for XPax-2a(1), Y10120 for XPax-2b(2), Y10121 for XPax2a(3), Y10122 for XPax-2a(4), Y10123 for XPax-2a(5), AJ000666 for XPax-2(6), AJ000667 for XPax-2a(7), AJ000668 for XPax-2b(8), and AJ000669 for XPax-2(9).
RNA isolation
Total RNA was isolated from unfertilized eggs, embryos and explants using the guanidinium-isothiocyanate method (TRIzol Reagent; Gibco). The RNA was precipitated with 1/ 10 vol. of 0.5 M sodium acetate (pH 5.2) and 2 vols. of 100% ethanol. Precipitated RNA was washed with 70% ethanol and resuspended in an appropriate volume of water. RNA concentrations were determined spectrophotometrically.
RT-PCR and Southern blot analysis
For amplification of cDNAs encoding alternatively spliced Pax-2 transcripts, total RNA was extracted from unfertilized eggs, embryos of different developmental stages, and from tissue samples (heads, pronephric explants, and animal caps) as described above. A mixture of XPax-2 antisense primers (XP-11, XP-24, XP-31, XP-63; 0.2 pmol each) was used to synthesize first-strand cDNAs from 10 mg of total RNA as described in Section 4.4. Furthermore, antisense primers (EF1a-2, GAPDH-2, H4-2 and ODC-2; 0.2 pmol each) complementary to Xenopus elongation factor 1a (EF1a), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), histone H4 and ornithine decarboxylase (ODC), mRNAs were included in the cDNA synthesis reaction to control for equal mRNA concentrations. One-fortieth of the cDNA preparation was used as template for subsequent amplification by PCR. Where cloned XPax-2 cDNAs were used as templates for PCR, purified plasmids were added as templates at 1 ng per 50-ml reaction. Each primer was added at 50 pmol. The amplification parameters were 94°C for 1 min, 48°C for 40 s, and 72°C for 35 cycles followed by 10 min at 72°C. One-third of the amplification product was size fractionated on either a 4% or 6% NuSieve 3:1 agarose gel.
Agarose gels were subjected to Southern blotting and hybridized with radiolabeled XPax-2-specific probes for unequivocal identification of amplification products encoding XPax-2 sequences. In brief, amplification products were capillary blotted onto nylon membranes (Hybond-N + , Amersham) in 0.4 N NaOH and crosslinked to the membrane by UV-irradiation (UV Stratalinker 1800, Stratagene). The filters were hybridized for 18 h in hybridization buffer (5× SSPE, 5× Denhardt's solution, 0.5% SDS, 20 mg/ml denatured fragmented Salmon sperm DNA) at 65°C with a radiolabeled probe. After hybridization, the filters were washed twice for 10 min in 2× SSPE, 0.1% (w/v) SDS at room temperature and once for 10 min in 0.2× SSPE, 0.1% (w/v) SDS at 65°C. DNA for the synthesis of radiolabeled probes to detect splicing in the paired domain region (probe 1; primers: XP-25 and XP-31) or the octapeptide region (probe 2; primers: XP-59 and XP-11) were generated by PCR with XPax-2a(1) cDNA (1 ng per 50-ml reaction) as template DNA. The purified amplification products were radiolabeled by ran-dom priming as described (see Section 4.4.). In all other cases, probe 3 directed against both allelic forms of exon 10 was used for hybridization. Radiolabeled probe 3 DNA was generated by PCR using the primers XP-62 and XP-63 and XPax-2a (1) and XPax-2b(2) cDNAs as templates. PCR was performed in a final volume of 30 ml containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 3 mM MgCl 2 , 16 mM of dATPs, dGTPs and dTTPs, 5 pmol of [ 32 P]dCTP, 1 pmol of each primer (XP-62 and XP-63), and 1 unit of Taq DNA polymerase (Perkin-Elmer). The amplification parameters were 94°C for 45 s, 48°C for 2 min, and 72°C for 1 min for 10 cycles. The radiolabeled probe 3 was purified using a G50 Sephadex column (Boehringer Mannheim) according to the manufacturer's recommendations.
Amplification products were verified by DNA sequencing as follows. After separation by agarose gel electrophoresis, bands were excised from the gel, purified and subcloned into the PCR2.1 vector (Original TA Cloning Kit, Invitrogen) according to the manufacturer's recommendations.
Primers
The following primers were used for cDNA synthesis and PCR amplification: 
Whole mount in situ hybridization and probe synthesis
Whole mount in situ hybridization was performed using digoxigenin-labeled RNA probes (Harland, 1991) . The standard protocol was modified by replacing methanol with ethanol, and by omitting the RNase digestion step. Fixed animal cap explants were bleached in 70% ethanol/10% H 2 O 2 prior to in situ hybridization.
The following plasmids were constructed for probe synthesis: (a) plasmid Bs4A.3, containing the entire coding sequence (nucleotides 19-1203) of XPax-2a (1) (2); (e) pBs7C.1, containing exon 9 (nucleotides 988-1197) of XPax-2b(2); and (f) pBs10C.1, containing exon 11 (nucleotides 1140-1238) of XPax-2a(3). The plasmids were generated using PCR-based subcloning procedures. The PCR primers were designed with EcoRI (for sense primers) and XbaI (for antisense primers) restriction sites for convenient ligation. Amplification products were ligated into a Bluescript II SK + vector.
Digoxigenin-labeled antisense RNA probes were synthesized with T3 RNA polymerase (MBI Fermentas) from EcoRI linearized plasmids. For control purposes, sense probes were synthesized with T7 RNA polymerase from XbaI linearized plasmids. The in vitro synthesized probes had the following approximate sizes: 1.2 kb for plasmid Bs4A.3; 0.4 kb for plasmid Bs4B.4; 0.5 kb for plasmid Bs10B.4′; 0.6 kb for plasmid Bs7B.5; 0.2 kb for plasmid Bs7C.1; and 0.1 kb for plasmid Bs10C.1.
Stained embryos were visualized and photographed using a Zeiss STEMI 2000-C stereoscopic microscope equipped with a Zeiss MC80 camera using either Kodak Ektachrome 64T or Fujichrome 64T professional slide film. Color slides were scanned using a slide scanner (Polaroid SprintScan 35), and processed using Adobe Photoshop 3.0 and Canvas 3.0 software.
.Tissue sectioning
Embryos stained in whole mount were fixed for 1-2 h in MEMFA (Harland, 1991) , washed with PBS and embedded in 3% low-melting agarose (SeaPlaque, FMC BioProducts). 50-100 mm sections were cut with a vibrating blade microtome (Leica VT1000M). Photographs were taken and processed exactly as described above.
